Guardant Health insider reports 150,000-share gift

Guardant Health, Inc. director and Co-Chief Executive Officer AmirAli Talasaz reported internal transfers of common stock interests involving family entities.

Rhea-AI Filing Summary

Guardant Health, Inc. director and Co-Chief Executive Officer AmirAli Talasaz reported internal transfers of common stock interests involving family entities. On 2026-08-10, 75,000 shares were transferred as a bona fide gift from the Talasaz and Eskandari 2017 Family Trust, reducing that indirect holding to 1,824,351 shares, and 75,000 shares were received by The Talasaz Family Foundation, which now holds 75,000 shares. A footnote states these transactions reflect changes in form of ownership between the trust and the foundation.

Insider Trade Summary

150,000 shares gifted

Gift 2 txns

Insider Talasaz AmirAli

Role Co-Chief Executive Officer

Type	Security	Shares	Price	Value
Gift	Common Stock F1	75,000	$0.00	$0.00
Gift	Common Stock F1	75,000	$0.00	$0.00

Holdings After Transaction: Common Stock — 1,824,351 shares (Indirect, Shares held by Talasaz and Eskandari 2017 Family Trust); Common Stock — 75,000 shares (Indirect, Shares held by the Talasaz Family Foundation)

Footnotes (1)

1. F1. Reflects changes in form of ownership from Talasaz and Eskandari 2017 Family Trust due to the gift of shares to The Talasaz Family Foundation.

Key Figures

Gifted shares from family trust: 75,000 shares Shares received by family foundation: 75,000 shares Trust holdings after transaction: 1,824,351 shares +3 more

6 metrics

Gifted shares from family trust 75,000 shares Common Stock disposed of by Talasaz and Eskandari 2017 Family Trust on 2026-08-10 as bona fide gift

Shares received by family foundation 75,000 shares Common Stock acquired by The Talasaz Family Foundation on 2026-08-10 as bona fide gift

Trust holdings after transaction 1,824,351 shares Indirect Common Stock holdings of Talasaz and Eskandari 2017 Family Trust following gift

Foundation holdings after transaction 75,000 shares Indirect Common Stock holdings of The Talasaz Family Foundation following receipt of gift

Per-share transaction price $0.0000 per share Reported price for both bona fide gift transactions of Guardant Health common stock

Total gifted shares 150,000 shares Aggregate shares involved in two bona fide gift transactions coded G

Key Terms

bona fide gift, indirect ownership, Family Trust, Family Foundation

4 terms

bona fide gift regulatory

"Each transaction is coded G and described as a bona fide gift."

A bona fide gift is a genuine, voluntary transfer of money, property, or benefits from one party to another made without expectation of repayment, services, or hidden conditions. Investors care because such gifts can affect company disclosures, related‑party transaction rules, tax treatment, and perceived conflicts of interest; think of it like someone giving you a present with no strings attached — but on a corporate scale, auditors and regulators need to verify it really is unconditional.

indirect ownership financial

"Both entries show ownership_type as indirect with family entities as holders."

Family Trust financial

"Shares held by Talasaz and Eskandari 2017 Family Trust are reported as indirect."

Family Foundation financial

"Shares held by The Talasaz Family Foundation are reported as indirect."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What transactions did GH insider AmirAli Talasaz report on this Form 4?

AmirAli Talasaz reported two bona fide gift transactions of Guardant Health common stock on 2026-08-10, moving 75,000 shares from the Talasaz and Eskandari 2017 Family Trust to The Talasaz Family Foundation as a change in form of ownership.

How many Guardant Health (GH) shares were transferred in the reported gifts?

A total of 150,000 shares were involved: 75,000 shares were disposed of by the Talasaz and Eskandari 2017 Family Trust and 75,000 shares were acquired by The Talasaz Family Foundation, both reported as bona fide gifts with a price of $0.0000 per share.

What are AmirAli Talasaz’s Guardant Health holdings after the Form 4 transactions?

After the 2026-08-10 transactions, the Talasaz and Eskandari 2017 Family Trust holds 1,824,351 shares indirectly, and The Talasaz Family Foundation holds 75,000 shares indirectly, as reported in the filing’s post-transaction share totals.

Were the Guardant Health (GH) Form 4 transactions market purchases or sales?

No. Both transactions were coded G, indicating bona fide gifts. The filing shows a per-share price of $0.0000, meaning they were not open-market purchases or sales but non-cash transfers between related family entities.

Does the Form 4 indicate a Rule 10b5-1 trading plan for GH insider AmirAli Talasaz?

No. The document-level indicator for Rule 10b5-1 plans is false, and the footnote only describes the transactions as changes in form of ownership between the family trust and The Talasaz Family Foundation, without referencing any trading plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 08/12/2026 - 06:20 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Talasaz AmirAli

(Last) (First) (Middle)

3100 HANOVER STREET

(Street)

PALO ALTO CALIFORNIA 94304

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Guardant Health, Inc. [ GH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Co-Chief Executive Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/10/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/10/2026		G		75,000(1)	D	$0	1,824,351	I	Shares held by Talasaz and Eskandari 2017 Family Trust
Common Stock	08/10/2026		G		75,000(1)	A	$0	75,000	I	Shares held by the Talasaz Family Foundation

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Reflects changes in form of ownership from Talasaz and Eskandari 2017 Family Trust due to the gift of shares to The Talasaz Family Foundation.

Remarks:

	/s/ John G. Saia, as attorney-in-fact for AmirAli Talasaz	08/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)